sprite-preloader
Anzeige
Mehr »
Freitag, 19.01.2018 Börsentäglich über 12.000 News von 578 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von Endpoints News

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
15:38PharmaMar stock tanks after PhIII ovarian cancer study flops
15:38Drugmakers take to Japan: 3 new drug approvals won by AstraZeneca, Merck, and EA Pharma
15:38AstraZeneca gives itself top marks for R&D productivity makeover - but the jury is still out
13:38Biogen, UCB step up to kick the tires at Acorda as buyout buzz grows - report
DoThe next Emflaza: Acer Therapeutics looks to take a page out of Marathon's book
DoCarmot closes $15M round to advance diabetes drug; Argos Therapeutics board clears reverse stock split, moves to small cap market
DoBeefing up its CAR-T pipeline, Gilead teams up with Pfizer on a lymphoma combo
DoInsider trading scam spurred by $11.2B Gilead deal earns a stretch in prison
DoNovartis ties a new round of biosimilar development programs to a partnership deal with India's Biocon
DoTired of being gouged for old, cheap therapies, a consortium of hospitals is going into the drug business - NYT
DoWith $58M in hand, the startup team at Pandion sets their sights on a next-gen approach to immunology
DoWhere the money is: Top 100 VCs investing in US biotechs during 2017
DoWith Pfizer in hot pursuit, J&J loses a critical patent fight as it scrambles for a new prostate cancer drug OK
MiFrance's Owkin raises $11M Series A for AI-aided drug development; AstraZeneca expands discovery deal with X-Chem
MiFDA and Pentagon forge breakthrough designation agreement
MiMerck KGaA taps UK cancer research organizations to feed pipeline
MiAfter a bruising year, Aeterna Zentaris inks a $24M upfront US pact for growth hormone asset
MiKymriah gets speed reviews in US and EU as Novartis looks to swiftly expand CAR-T indications
DiJuno shares rocket higher on word that Celgene is hunting a buyout deal
DiFDA commissioner Scott Gottlieb just broke a public promise on publishing CRLs - and yes, it matters
DiAveXis wants $400M more for promising SMA gene therapy; ShangPharma partners with Icahn School of Medicine at Mount Sinai
DiChina biotech unicorn Innovent in talks on $200M IPO and new funding - report
DiDevelopers are laying the foundation for a new biotech complex in California
DiGerman drugmaker files $21.6M IPO for skin cancer drug
DiEiger Bio scraps a mid-stage program after researchers record a clear flop in PAH